Clin2
NCT07404891Possibly a fitRecruiting

Study of ALT001 for knee osteoarthritis pain

Osteoarthritis

Treatments studied

Part of Bones, joints & muscles clinical trials.

This study tests whether a new medicine (ALT001) can safely reduce knee pain from osteoarthritis. If you join, you would stop your current pain medicines and take the study drug or a placebo for a set time, while being closely monitored.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
50 years to 75 years
Study type
Interventional

Who can take part

  • You are between 50 and 75 years old.
  • You have had knee pain on and off for at least the past month.
  • An X-ray in the last 6 months showed signs of osteoarthritis in your knee (like joint space narrowing or bone spurs).
  • Your knee pain when walking on flat ground or climbing stairs is moderate (a pain score of 4 to 8).
  • You have not used any painkillers for at least 2 weeks before the study, and you agree to avoid other pain medications during the trial (except the one given).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06805188Recruiting
Acupuncture for knee osteoarthritis

This study tests whether acupuncture can reduce pain and improve function for people with knee osteoarthritis. If you have had persistent knee pain and meet the age and health requirements, this treatment may offer relief without surgery or strong medications.

Nanchang, Jiangxi
NCT07203547Not yet recruiting· Phase 4
Study of Laybon Tab. for knee osteoarthritis pain

This trial tests whether Laybon Tab. helps reduce knee pain in people with knee osteoarthritis. It is for adults aged 40 to 80 who have had knee pain for at least 3 months and are ready to stop other pain treatments during the study.

NCT06245109Recruiting· Phase 4
Pain medicine study for knee osteoarthritis

This study tests how well different pain medicines work for knee osteoarthritis and looks at brain patterns to understand why some people get more relief. It may help you find a treatment that works best for you.

Chicago, Illinois
NCT06343714Recruiting· Phase 1
Testing a new drug for knee osteoarthritis pain

This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.

Brisbane, Queensland
NCT07652372Enrolling by invitation· Phase 1
Injectable RAB001 for knee osteoarthritis (Phase 1b)

This trial tests an injectable medication called RAB001 for people with knee osteoarthritis that hasn't improved with other treatments. The goal is to see if it's safe and helps reduce pain.

Beijin, Beijin
NCT07226258Recruiting· Phase 3
Testing SL1002 for knee pain caused by osteoarthritis

This trial tests a study drug called SL1002 to see if it reduces knee pain from osteoarthritis. It may be an option for people with chronic knee pain who haven't found enough relief from current treatments.

Roseville, California

Hear when a new Osteoarthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.